U.S. Markets closed

Ampio Pharmaceuticals, Inc. (AMPE)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
0.66+0.07 (+11.67%)
At close: 3:59PM EDT
People also watch
ANTHACRXALIMMRNSGALE
Full screen
Previous Close0.60
Open0.60
Bid0.58 x 400
Ask0.63 x 2600
Day's Range0.59 - 0.67
52 Week Range0.38 - 1.14
Volume637,966
Avg. Volume331,185
Market Cap45.03M
Beta0.61
PE Ratio (TTM)-3.19
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • American City Business Journals6 months ago

    Colorado biotech's accountants express 'substantial doubt' about firm's future

    In a recent 10-K filing with the Securities and Exchange Commission, Douglas County-based Ampio (AMPE) said "a 'going concern' opinion could impair our ability to finance our operations through the sale of debt or equity securities or through bank financing. Ampio is developing Ampion, an anti-inflammatory drug designed to treat to severe pain associated with osteoarthritis of the knee , which company officials are excited about. In the history of the company, we have never been as close to realizing what we believe to be the full potential of Ampion, both from a regulatory perspective as well as commercial," said Michael Macaluso, chairman, and CEO, in a statement .

  • We're sorry this is all we were able to find about this topic.